• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nanobiotix S.A. - ADSs (NQ:NBTX)

    38.20 -1.24 (-3.14%)
    Streaming Delayed Price Updated: 11:57 AM EDT, Aug 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 54,504
    Open 38.92
    Bid (Size) 37.60 (200)
    Ask (Size) 38.45 (100)
    Prev. Close 39.44
    Today's Range 37.57 - 38.98
    52wk Range 6.970 - 57.14
    Shares Outstanding 34,432,122
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) 
    From Nanobiotix S.A.
    Via GlobeNewswire

    Performance

    YTD
    +72.6%
    +72.6%
    1 Month
    -2.4%
    -2.4%
    3 Month
    -26.6%
    -26.6%
    6 Month
    +58.4%
    +58.4%
    1 Year
    +416.2%
    +416.2%

    More News

    Read More
    News headline image
    Nanobiotix Provides First Quarter 2026 Operational and Financial Update
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Joins the Euronext Tech Leaders Index
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX Announces Closing of Global Offering
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Launch of Global Follow-On Offering
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX Statement Regarding Recent Media Speculation
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX to Participate in Investor Conferences in March
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Voting Rights and Shares Capital of the Company
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
    From Nanobiotix S.A.
    Via GlobeNewswire
    News headline image
    Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
    From Nanobiotix S.A.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nanobiotix S.A. - ADSs publicly traded?
    Yes, Nanobiotix S.A. - ADSs is publicly traded.
    What exchange does Nanobiotix S.A. - ADSs trade on?
    Nanobiotix S.A. - ADSs trades on the Nasdaq Stock Market
    What is the ticker symbol for Nanobiotix S.A. - ADSs?
    The ticker symbol for Nanobiotix S.A. - ADSs is NBTX on the Nasdaq Stock Market
    What is the current price of Nanobiotix S.A. - ADSs?
    The current price of Nanobiotix S.A. - ADSs is 38.20
    When was Nanobiotix S.A. - ADSs last traded?
    The last trade of Nanobiotix S.A. - ADSs was at 08/13/26 11:57 AM ET
    What is the market capitalization of Nanobiotix S.A. - ADSs?
    The market capitalization of Nanobiotix S.A. - ADSs is 1.32B
    How many shares of Nanobiotix S.A. - ADSs are outstanding?
    Nanobiotix S.A. - ADSs has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.